Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Scrap and Sale of services for the year ending 31-Mar-2021.

The Relative Strength Index of the stock stood at 62.11 on Tuesday.

“The excess growth in the positions that have been taken in commodity stocks could bring down the stock prices as traders would probably want to book profits or cut short losses.”

The stock quoted a 52-week high price of Rs 170.0 and a 52-week low of Rs 81.25.

In the spot market, highest purity gold was sold at Rs 46,282 per 10 gram while silver was priced at Rs 59,714 per kg on Monday, according to the Indian Bullion and Jewellers Association.

"We believe Beijing would only be compelled to step in if there is a far-reaching contagion causing multiple major developers to fail and posing systemic risks to the economy," the rating agency said in a note dated Sept 20.

A major test comes this week, with Evergrande due to pay $83.5 million in interest relating to its March 2022 bond on Thursday. It has another $47.5 million payment due on Sept. 29 for March 2024 notes.

“Once recovery begins, India will be dynamic enough to sustain for a few years.”

The top five smallcap schemes — Quant Smallcap Fund (up 110 per cent), Kotak Smallcap Fund (up 96 per cent), L&T Emerging Businesses Fund (up 89 per cent), HDFC Smallcap Fund (up 88 per cent) and Nippon India Small Cap Fund (up 88 per cent) — have delivered up to 110 per cent returns in last one year.

“We may just get caught in the crossfire. Our economy may be doing okay in comparison but we will get impacted by liquidity, the same way we got positively impacted by liquidity in the last one year. ”